$30.07
0.76[2.59%]
At close: Apr 26
$30.07
0[0.00%]
After Hours: 4:20PM EDT
Supernus Pharmaceuticals
(NASDAQ:SUPN)Supernus Pharmaceuticals Stock (NASDAQ:SUPN), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2024 | SUPN | Supernus Pharmaceuticals | FY | 2024 | — | — | — | $580.00M | $620.00M | $622.52M | Get Alert |
| 11/08/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $590.00M | $610.00M | $594.28M | Get Alert |
| 08/08/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $580.00M | $620.00M | $609.65M | Get Alert |
| 05/09/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $580.00M | $620.00M | $599.79M | Get Alert |
| 02/28/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $580.00M | $620.00M | $590.51M | Get Alert |
| 11/08/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $650.00M | $680.00M | $674.36M | Get Alert |
| 08/04/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $673.56M | Get Alert |
| 06/09/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $673.56M | Get Alert |
| 05/09/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $683.81M | Get Alert |
| 04/13/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $685.46M | Get Alert |
| 04/04/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $685.46M | Get Alert |
| 02/28/2022 | SUPN | Supernus Pharmaceuticals | Q4 | 2021 | — | — | — | $155.00M | $155.00M | $149.42M | Get Alert |
| 02/28/2022 | SUPN | Supernus Pharmaceuticals | FY | 2021 | — | — | — | $567.50M | $567.50M | $569.13M | Get Alert |
| 02/28/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $707.32M | Get Alert |
| 11/03/2021 | SUPN | Supernus Pharmaceuticals | FY | 2021 | — | — | — | $550.00M | $570.00M | $560.68M | Get Alert |
| 08/04/2021 | SUPN | Supernus Pharmaceuticals | FY | 2021 | — | — | — | $550.00M | $580.00M | $558.02M | Get Alert |
| 05/05/2021 | SUPN | Supernus Pharmaceuticals | FY | 2021 | — | — | — | $550.00M | $580.00M | $569.54M | Get Alert |
| 02/25/2021 | SUPN | Supernus Pharmaceuticals | FY | 2021 | — | — | — | $550.00M | $580.00M | $581.47M | Get Alert |
| 11/03/2020 | SUPN | Supernus Pharmaceuticals | FY | 2020 | — | — | — | $500.00M | $525.00M | $486.54M | Get Alert |
FAQ
What is the most recent guidance for Supernus Pharmaceuticals (SUPN)?
There have been no specific sales or earnings guidance reported for Supernus Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.